Topic archive

united states

7 stories

10/6/2026

FDA seeks public input on ibogaine research

A request for information asks researchers, clinicians and the public how ibogaine trials should be designed, dosed and monitored.

10/5/2026

First federally backed ibogaine trials mark a shift in psychedelic research.

10/5/2026

The FDA is evaluating guidelines for ibogaine clinical trials.

10/5/2026

First federally backed ibogaine trials mark a significant step in psychedelic research.

7/16/2026

Veterans share recovery stories, highlighting ibogaine's potential.

7/15/2026

Federal support for ibogaine and other psychedelics aims to aid veterans with PTSD.

7/8/2026

Ibogaine remains illegal in the U.S., yet clinical trials are underway.